Status:
COMPLETED
To Demonstrate the Relative Bioequivalency Comparing Geneva's 10 mg Glipizide Tablets To Roerig's 10 mg Glucotrol Tablets
Lead Sponsor:
Sandoz
Conditions:
Type 2 Diabetes
Eligibility:
MALE
18-50 years
Phase:
PHASE1
Brief Summary
To demonstrate the relative bioequivalency comparing Geneva's 10 mg Glipizide tablets to Roerig's 10 mg Glucotrol tablets.
Eligibility Criteria
Inclusion
- No clinically significant abnormal finding on physical exam, medical history, or clinical laboratory results on screening.
Exclusion
- Positive test results for HIV or hepatitis B or C.
- Treatment for drug or alcohol dependence.
Key Trial Info
Start Date :
October 1 1992
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 1992
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT00946504
Start Date
October 1 1992
End Date
October 1 1992
Last Update
March 28 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.